Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009

Influenza and other Respiratory Viruses

Volumn 5, Issue 3, 2011, Pages 148-156

  Khandaker, Gulam ^a   Dierig, Alexa ^a   Rashid, Harunor ^a   King, Catherine ^a   Heron, Leon ^a   Booy, Robert ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Clinical features; Epidemiology; H1N1 Influenza; Pandemic

Indexed keywords

AGE DISTRIBUTION; CHRONIC DISEASE; CLINICAL FEATURE; COMMUNITY; FATALITY; FEVER; HEADACHE; HOSPITAL PATIENT; HUMAN; INFECTION RATE; INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; MYALGIA; OUTPATIENT; PANDEMIC INFLUENZA; PRIORITY JOURNAL; REVIEW; RHINORRHEA; SCHOOL; SEX RATIO; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

ADULT; AGE DISTRIBUTION; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; PANDEMICS; YOUNG ADULT;

EID: 79953781217     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2011.00199.x     Document Type: Review

References (83)

1. Chan M, World Health Organization. World now at the start of 2009 influenza pandemic. Statement to the press by WHO Director-General, 11 June 2009. Available at (Accessed 5 May 2010).
2. Shinde V, Bridges CB, Uyeki TM et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 2009; 360:2616-2625.
3. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-2615.
4. World Health Organization (WHO). Influenza A(H1N1) - update 50. Laboratory-confirmed cases of new influenza A(H1N1) as officially reported to WHO by States Parties to the International Health Regulations (2005), 17 June 2009. Available at (Accessed 4 Jun 2010).
5. World Health Organization (WHO). Pandemic (H1N1) 2009 - update 60. Laboratory-confirmed cases of pandemic (H1N1) 2009 as officially reported to WHO by States Parties to the IHR (2005) as 31 July 2009. Available at (Accessed 5 May 2010).
6. World Health Organization (WHO). Influenza (seasonal). Fact sheet No 211. Revised March 2003. Available at (Accessed 24 Oct 2009).
7. Taubenberger JK, Morens DM. 1918 influenza: the mother of all pandemics. Emerg Infect Dis 2006; 12:15-22.
8. Simonsen L, Olson DR, Viboud C et al. Pandemic influenza and mortality: past evidence and projections for the future; in Knobler SL, Mack A, Mahmoud A, Lemon SM (eds): The Threat of Pandemic Influenza: Are We Ready? Workshop Summary. Washington, DC: National Academies Press, 2005; 89-114.
9. Andreasen V, Viboud C, Simonsen L. Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies. J Infect Dis 2008; 197:270-278.
10. Viboud C, Miller M, Olson D, Osterholm M, Simonsen L. Preliminary estimates of mortality and years of life lost associated with the 2009 A/H1N1 pandemic in the US and comparison with past influenza seasons. PLoS Curr 2010:RRN1153.
11. World Health Organization (WHO). Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. November 2009. Available at (Accessed 4 Jun 2010).
12. ANZIC Influenza Investigators, Webb SA, Pettilä V et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 361:1925-1934.
13. Domínguez-Cherit G, Lapinsky SE, Macias AE et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009; 302:1880-1887.
14. Kumar A, Zarychanski R, Pinto R et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302:1872-1879.
15. Coker R. Swine flu. BMJ 2009; 338:b1791.
16. World Health Organization (WHO). Clinical features of severe cases of pandemic influenza. Pandemic (H1N1) 2009 briefing note 13. 16 October 2009. Available at (Accessed 25 Jun 2010).
17. Centers for Disease Control and Prevention (CDC). Interim guidance on case definitions to be used for investigations of novel influenza A (H1N1) cases. 1 June 2009. Available at (Accessed 25 Jun 2010).
18. Health Protection Agency (HPA). Pandemic (H1N1) 2009 influenza: information for health professionals. Available at (Accessed 20 Apr 2010).
19. Nishiura H. The virulence of pandemic influenza A (H1N1) 2009: an epidemiological perspective on the case-fatality ratio. Expert Rev Respir Med 2010; 4:329-338.
20. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010; 375:1100-1108.
21. The World Bank. Country and lending groups. Available at (Accessed 10 Sep 2010).
22. Hackett S, Hill L, Patel J et al. Clinical characteristics of paediatric H1N1 admissions in Birmingham, UK. Lancet 2009; 374:605.
23. Health Protection Agency West Midlands H1N1v Investigation Team. Preliminary descriptive epidemiology of a large school outbreak of influenza A(H1N1)v in the West Midlands, United Kingdom, May 2009. Euro Surveill 2009; 14(27):pii=19264.
24. Health Protection Agency and Health Protection Scotland new influenza A(H1N1) investigation teams. Epidemiology of new influenza A(H1N1) in the United Kingdom, April-May 2009. Euro Surveill 2009; 14(19):pii=19213.
25. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, HPA Northern Ireland Swine influenza investigation teams. Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April-June 2009. Euro Surveill 2009; 14(22):pii=19232.
26. Smith A, Coles S, Johnson S, Saldana L, Ihekweazu C, O'Moore E. An outbreak of influenza A(H1N1)v in a boarding school in South East England, May-June 2009. Euro Surveill 2009; 14(27):pii=19263.
27. Lister P, Reynolds F, Parslow R et al. Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet 2009; 374:605-607.
28. Cutler J, Schleihauf E, Hatchette TF et al. Investigation of the first cases of human-to-human infection with the new swine-origin influenza A (H1N1) virus in Canada. CMAJ 2009; 181:159-163.
29. Rizzo C, Declich S, Bella A et al. Enhanced epidemiological surveillance of influenza A(H1N1)v in Italy. Euro Surveill 2009; 14(27):pii=19266.
30. Shimada T, Gu Y, Kamiya H et al. Epidemiology of influenza A(H1N1)v virus infection in Japan, May-June 2009. Euro Surveill 2009; 14(24):pii=19244.
31. Komiya N, Gu Y, Kamiya H et al. Clinical features of cases of influenza A (H1N1)v in Osaka prefecture, Japan, May 2009. Euro Surveill 2009; 14(29):pii=19272.
32. Anonymous Human infection with new influenza A (H1N1) virus: clinical observations from a school-associated outbreak in Kobe, Japan, May 2009. Wkly Epidemiol Rec 2009; 84:237-244.
33. Belgian working group on influenza A(H1N1)v. Influenza A(H1N1)v virus infections in Belgium, May-June 2009. Euro Surveill 2009; 14(28):pii=19270.
34. Gutiérrez I, Litzroth A, Hammadi S et al. Community transmission of influenza A (H1N1)v virus at a rock festival in Belgium, 2-5 July 2009. Euro Surveill 2009; 14(31):pii=19294.
35. New influenza A(H1N1) investigation teams. New influenza A(H1N1) virus infections in France, April-May 2009. Euro Surveill 2009; 14(21):pii=19221.
36. Influenza A(H1N1)v investigation teams, Levy-Bruhl D, Vaux S. Modified surveillance of influenza A(H1N1)v virus infections in France. Euro Surveill 2009; 14(29):pii=19276.
37. Gilsdorf A, Poggensee G, on behalf of the working group pandemic influenza A(H1N1)v. Influenza A(H1N1)v in Germany: the first 10, 000 cases. Euro Surveill 2009; 14(34):pii=19318.
38. Novel influenza A(H1N1) investigation team. Description of the early stage of pandemic (H1N1) 2009 in Germany, 27 April-16 June 2009. Euro Surveill 2009; 14(31):pii=19295.
39. Tinoco Y, Razuri H, Ortiz EJ et al. Preliminary population-based epidemiological and clinical data on 2009 pandemic H1N1 influenza A (pH1N1) from Lima, Peru. Influenza Other Respi Viruses 2009; 3:253-256.
40. Munayco CV, Gómez J, Laguna-Torres VA et al. Epidemiological and transmissibility analysis of influenza A(H1N1)v in a southern hemisphere setting: Peru. Euro Surveill 2009; 14(32):pii=19299.
41. Martin J, O'Donnell J, Igoe D et al. Enhanced surveillance of initial cases of pandemic H1N1 2009 influenza in Ireland, April-July 2009. Euro Surveill 2009; 14(38):pii=19337.
42. Bin C, Xingwang L, Yuelong S et al. Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus infection, People's Republic of China, 2009. Emerg Infect Dis 2009; 15:1418-1422.
43. Lytras T, Theocharopoulos G, Tsiodras S et al. Enhanced surveillance of influenza A(H1N1)v in Greece during the containment phase. Euro Surveill 2009; 14(29):pii=19275.
44. Ciblak MA, Albayrak N, Odabas Y et al. Cases of influenza A(H1N1)v reported in Turkey, May-July 2009. Euro Surveill 2009; 14(32):pii=19304.
45. Castro-Jiménez MA, Castillo-Pabón JO, Rey-Benito GJ et al. Epidemiologic analysis of the laboratory-confirmed cases of influenza A(H1N1)v in Colombia. Euro Surveill 2009; 14(30):pi=19284.
46. Gianella A, Walter A, Revollo R, Loayza R, Vargas J, Roca Y. Epidemiological analysis of the influenza A(H1N1)v outbreak in Bolivia, May-August 2009. Euro Surveill 2009; 14(35):pii=19323.
47. Hahné S, Donker T, Meijer A et al. Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases. Euro Surveill 2009; 14(27):pii=19267.
48. Liang M, Lye DC, Chen MI et al. New influenza A (H1N1) 2009 in Singapore: the first ten adult imported cases. Singapore Med J 2009; 50:581-583.
49. Surveillance Group for New Influenza A(H1N1) Virus Investigation and Control in Spain. New influenza A(H1N1) virus infections in Spain, April-May 2009. Euro Surveill 2009; 14(19):pii=19209.
50. Oliveira WK, Carmo EH, Penna GO et al. Pandemic H1N1 influenza in Brazil: analysis of the first 34, 506 notified cases of influenza-like illness with severe acute respiratory infection (SARI). Euro Surveill 2009; 14(42):pii=19362.
51. Koliou M, Soteriades ES, Toumasi MM, Demosthenous A, Hadjidemetriou A. Epidemiological and clinical characteristics of influenza A(H1N1)v infection in children: the first 45 cases in Cyprus, June-August 2009. Euro Surveill 2009; 14(33):pii=19312.
52. Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009; 374:2072-2079.
53. Crum-Cianflone NF, Blair PJ, Faix D et al. Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries. Clin Infect Dis 2009; 49:1801-1810.
54. Centers for Disease Control and Prevention (CDC). Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:536-541.
55. Jamieson DJ, Honein MA, Rasmussen SA et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374:451-458.
56. Louie JK, Acosta M, Winter K et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302:1896-1902.
57. Centers for Disease Control and Prevention (CDC). 2009 pandemic influenza A (H1N1) virus infections - Chicago, Illinois, April-July 2009. MMWR Morb Mortal Wkly Rep 2009; 58:913-918.
58. Jain S, Kamimoto L, Bramley AM et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361:1935-1944.
59. BinSaeed AA. Characteristics of pandemic influenza A (H1N1) infection in patients presenting to a university hospital in Riyadh, Saudi Arabia. Ann Saudi Med 2010; 30:59-62.
60. Al-Khuwaitir TS, Al-Abdulkarim AS, Abba AA et al. H1N1 influenza A: preliminary evaluation in hospitalized patients in a secondary care facility in Saudi Arabia. Saudi Med J 2009; 30:1532-1536.
61. Libster R, Bugna J, Coviello S et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 2010; 362:45-55.
62. Cao B, Li XW, Mao Y et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009; 361:2507-2517.
63. Kelly H, Grant K, Williams S, Smith D. H1N1 swine origin influenza infection in the United States and Europe in 2009 may be similar to H1N1 seasonal influenza infection in two Australian states in 2007 and 2008. Influenza Other Respi Viruses 2009; 3:183-188.
64. Hancock K, Veguilla V, Lu X et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-1952.
65. Ikonen N, Strengell M, Kinnunen L et al. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill 2010; 15(5):pii=19478.
66. Rizzo C, Rota MC, Bella A et al. Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine 2010; 28:3558-3562.
67. Itoh Y, Shinya K, Kiso M et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009; 460:1021-1025.
68. Booy R, Khandaker G, Heron LG et al. Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians. Med J Aust 2011; 194:19-23.
69. Miller MA, Viboud C, Balinska M, Simonsen L. The signature features of influenza pandemics - implications for policy. N Engl J Med 2009; 360:2595-2598.
70. Australian Institute of Health and Welfare (AIHW). 2009 Adult Vaccination Survey. Provisional topline results for H1N1 vaccination uptake. 8 February 2010. Available at (Accessed 5 May 2010).
71. Centers for Disease Control and Prevention (CDC). People at high risk of developing flu-related complications. November 10, 2009. Available at (Accessed 5 Jun 2010).
72. Nishiura H. Case fatality ratio of pandemic influenza. Lancet Infect Dis 2010; 10:443-444.
73. Nishiura H. The relationship between the cumulative numbers of cases and deaths reveals the confirmed case fatality ratio of a novel influenza A (H1N1) virus. Jpn J Infect Dis 2010; 63:154-156.
74. Nishiura H, Chowell G, Safan M, Castillo-Chavez C. Pros and cons of estimating the reproduction number from early epidemic growth rate of influenza A (H1N1) 2009. Theor Biol Med Model 2010; 7:1.
75. Nishiura H, Klinkenberg D, Roberts M, Heesterbeek JA. Early epidemiological assessment of the virulence of emerging infectious diseases: a case study of an influenza pandemic. PLoS ONE 2009; 4(8):e6852.
76. Donaldson LJ, Rutter PD, Ellis BM et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009; 339:b5213.
77. Presanis AM, De Angelis D, New York City Swine Flu Investigation Team et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med 2009; 6(12):e1000207.
78. Wilson N, Baker MG. The emerging influenza pandemic: estimating the case fatality ratio. Euro Surveill 2009; 14(26):pii=19255.
79. Garske T, Legrand J, Donnelly CA et al. Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ 2009; 339:b2840.
80. Mayor M. Flu experts warn of need for pandemic plans. BMJ 2000; 321:852.
81. Barbour V, Clark J, Jones S, Peiperl L, Veitch E, Yamey G. Science must be responsible to society, not to politics. PLoS Med 2010; 7(1):e1000222.
82. Ong CW, Ho KY, Hsu LY, Lim AY, Fisher DA, Tambyah PA. Reacting to the emergence of swine-origin influenza A H1N1. Lancet Infect Dis 2009; 9:397-398.
83. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6(7):e1000097.